Scrutinizing a Stem Cell Trial
Wired News has an interesting discussion of a clinical stem cell trial with the CEO of Geron, a California based stem cell company. The author takes time to discuss some of the process and hurdles that are faced by a company who wishes to engage in early clinical trials. From the article: "After an hour of speaking to Okarma, fears of a half-baked trial dissipated. He readily answered my many questions. If he didn't have the animal data to answer a query, he didn't try to dance around that fact. Okarma outlined a structured but malleable trial. I initially had reservations about safety, but Okarma emphasized that if the animal data is not good, the study will not move forward until problems are addressed."
I am sure all the rats are realy happy we humans do all this reasearch to cure them of all these diseases and injuries.
I am sure all the rats are realy happy we humans do all this reasearch to cure them of all these diseases and injuries.
They would probably be happier if we didn't intentionally paralyze them first!
Religion for nerds. Stuff that really matters
Wanted: Assistant for lab. Will be required to break spines of rats for further research. Flexible hours. Bring own hammer.
I've always sought a career in making rats happier. Or was it humans? I not sure anymore. Anyways, you can leave some cheese outside this evening if it makes you feel better.